Biomarkers · 2013 · 10 citations · 67 references
MedicineImmunologyOncologyCancer ImmunologyPediatric OncologyTumor ImmunologyCytokine BiologyCytokines In Tumor ImmunityImmuno-oncology BiomarkersInflammatory SignalingPediatric SarcomasTumor ImmunopathologyCytokine Biomarkers In CancerImmune Biomarker ProfilingInflammatory Cytokine ProfilesInterleukin-10 Mediated ImmunosuppressionInterleukin-10 To Interleukin-6 RatioInterleukin-12 AxisTumor-associated CytokinesTumor-associated Inflammation
CONTEXT: The roles of interleukin 10 (IL-10) and IL-12 in regulation of cancer growth and Th1/Th2 immune responses towards cancer are unclear. OBJECTIVE: To establish the prognostic significance of serum IL-10 and IL-12 in paediatric soft tissue sarcomas (STS). MATERIALS AND METHODS: ELISA determinations of cytokines were performed as pre-treatment in 59 children with STS and 30 healthy controls. RESULTS: Elevated IL-10 and decreased IL-12 serum levels correlated with advanced disease, poor response to chemotherapy and poor outcome. IL-10 ≥ 9.5 pg/ml, IL-12 ≤ 65 pg/ml and lymph nodes involvement independently predicted poor overall survival (OS) in multivariate Cox analysis. CONCLUSION: Serum IL-10/IL-12 balance determination may facilitate to assess risk groups and prognosis in childhood STS.
67
IL-10 inhibits cytokine production by activated macrophages
David Fiorentino, Albert Zlotnik, Tim R. Mosmann et al. · The Journal of Immunology · 1991 · 2.9K citations · Full text
Gianfranco Del Prete, Marco Carli, Fabio Almerigogna et al. · The Journal of Immunology · 1993 · 930 citations · Full text
The intergroup rhabdomyosarcoma study-I.A final report
Harold M. Maurer, William M. Crist, Walter Lawrence et al. · Cancer · 1988 · 910 citations